Q2 2024 EPS Estimates for Aspen Aerogels, Inc. (NYSE:ASPN) Boosted by Seaport Res Ptn

Aspen Aerogels, Inc. (NYSE:ASPNFree Report) – Equities research analysts at Seaport Res Ptn lifted their Q2 2024 EPS estimates for Aspen Aerogels in a research note issued to investors on Monday, May 6th. Seaport Res Ptn analyst T. Curran now forecasts that the construction company will post earnings of $0.08 per share for the quarter, up from their prior estimate of ($0.08). The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.03 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels’ Q3 2024 earnings at $0.06 EPS, Q4 2024 earnings at $0.16 EPS, FY2024 earnings at $0.63 EPS and Q4 2025 earnings at $0.18 EPS.

Several other research firms also recently issued reports on ASPN. B. Riley boosted their price objective on Aspen Aerogels from $24.00 to $30.00 and gave the company a “buy” rating in a report on Friday, May 3rd. HC Wainwright lifted their target price on Aspen Aerogels from $20.00 to $25.00 and gave the company a “buy” rating in a report on Friday, May 3rd. Roth Mkm restated a “buy” rating and set a $22.00 target price on shares of Aspen Aerogels in a research note on Tuesday, April 30th. Piper Sandler lifted their price target on Aspen Aerogels from $20.00 to $29.00 and gave the stock an “overweight” rating in a report on Friday, May 3rd. Finally, TheStreet raised Aspen Aerogels from a “d+” rating to a “c-” rating in a report on Wednesday, March 6th. One analyst has rated the stock with a sell rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $25.17.

View Our Latest Stock Analysis on Aspen Aerogels

Aspen Aerogels Price Performance

NYSE:ASPN opened at $26.64 on Thursday. The company has a market capitalization of $2.03 billion, a P/E ratio of -60.55 and a beta of 1.97. The company has a quick ratio of 3.29, a current ratio of 4.01 and a debt-to-equity ratio of 0.24. Aspen Aerogels has a 52 week low of $5.32 and a 52 week high of $27.09. The stock’s fifty day moving average is $17.27 and its two-hundred day moving average is $14.13.

Aspen Aerogels (NYSE:ASPNGet Free Report) last issued its earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.11. The company had revenue of $84.22 million during the quarter, compared to analysts’ expectations of $83.82 million. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. During the same period in the prior year, the business earned ($0.20) EPS.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Banque Cantonale Vaudoise lifted its position in shares of Aspen Aerogels by 37.5% during the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after acquiring an additional 1,252 shares during the period. McAdam LLC acquired a new stake in shares of Aspen Aerogels in the 4th quarter worth about $191,000. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Aspen Aerogels by 38.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after buying an additional 3,607 shares during the period. Cornerstone Investment Partners LLC bought a new stake in Aspen Aerogels in the 4th quarter valued at about $230,000. Finally, Raymond James Financial Services Advisors Inc. purchased a new stake in shares of Aspen Aerogels in the fourth quarter worth about $265,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insider Activity

In related news, SVP Corby C. Whitaker sold 55,159 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $25.01, for a total transaction of $1,379,526.59. Following the transaction, the senior vice president now owns 131,533 shares in the company, valued at approximately $3,289,640.33. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 4.30% of the stock is owned by corporate insiders.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Recommended Stories

Earnings History and Estimates for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.